The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Tirzepatide is available through both the type 2 diabetes medication Mounjaro and weight-loss medication Zepbound ... Integrated Research Database. The average age of selected study participants ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Mounjaro, an injectable medication designed to support weight loss, works by imitating the effects of two natural hormones, ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...

After one year, the tirzepatide group experienced an average weight loss of 21.4% and a 0.67 percentage point reduction in HbA1c, while the semaglutide group saw an average 9.1% weight loss and ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...